Shenzhen Chipscreen Biosciences Co (688321) — Cash Flow Reinvestment Rate

Latest as of September 2025: 27.48x

Shenzhen Chipscreen Biosciences Co (688321) has a Cash Flow Reinvestment Rate of 27.48x as of September 2025, reinvesting CN¥61.73 Million (capex CN¥61.73 Million ) from operating cash flow of CN¥2.25 Million. Check cash flow quality index of Shenzhen Chipscreen Biosciences Co to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

27.48x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥61.73 Million
Capex + Investments

Operating Cash Flow

CN¥2.25 Million
CNY

Capital Expenditures

CN¥61.73 Million
CNY

Shenzhen Chipscreen Biosciences Co Cash Flow Reinvestment Rate (2016–2024)

Historical reinvestment intensity for Shenzhen Chipscreen Biosciences Co across 7 annual periods. Explore Shenzhen Chipscreen Biosciences Co cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Shenzhen Chipscreen Biosciences Co (2016–2024)

Year-by-year capital reinvestment analysis for Shenzhen Chipscreen Biosciences Co. For live market cap and broader valuation context, see 688321 market cap.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2024 3.89x CN¥296.04 Million CN¥76.13 Million CN¥268.49 Million ▼ -86.0%
2022 27.76x CN¥1.20 Billion CN¥43.30 Million CN¥400.17 Million ▲ +548.7%
2021 4.28x CN¥534.01 Million CN¥124.78 Million CN¥288.46 Million ▼ -26.2%
2020 5.80x CN¥542.98 Million CN¥93.62 Million CN¥336.27 Million ▼ -50.5%
2018 11.71x CN¥266.74 Million CN¥22.78 Million CN¥140.74 Million ▼ -83.9%
2017 72.82x CN¥198.82 Million CN¥2.73 Million CN¥132.82 Million ▲ +2060.9%
2016 3.37x CN¥201.41 Million CN¥59.77 Million CN¥65.81 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow